4//SEC Filing
Atkins Michael B. 4
Accession 0000950170-25-086167
CIK 0001785530other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:10 PM ET
Size
5.4 KB
Accession
0000950170-25-086167
Insider Transaction Report
Form 4
Atkins Michael B.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+27,000→ 27,000 totalExercise: $1.29Exp: 2035-06-11→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0002004793
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:10 PM ET
- Size
- 5.4 KB